Mol Psychiatry 23(7):15551565 Maccora C et al (2020) One month weight loss predicts the efficacy of liraglutide in obese patients: data from a single center
SAFETY AND RESEARCH Preclinical studies : Most of the research on BPC-157 has been conducted in animal models, showing promising results related to soft tissue integrity, as well as other system-specific support such as the gut-brain axis, the detoxification capabilities within the liver, and even neurotransmitter balance
N-acetylcysteine as a therapeutic approach to post-COVID-19 pulmonary fibrosis adjunctive treatment
If therapeutic goals are not met with these measures, certain patient characteristics determine the further recommended treatment options
Research shows that at age 20, the average person has about 200 ng/mL of GHK in their plasma
If you've been following the medical weight loss conversation, you already know that injectable drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have fundamentally changed how medicine approaches obesity and metabolic health